ST中新(603996.SH)实控人陈德松解除轮候冻结及再冻结2165万股
格隆汇11月7日丨ST中新(603996.SH)公布,2019年11月6日,公司收到《股权司法冻结及司法划转通知》,获悉公司共同实际控制人之一陈德松持有的公司无限售流通股2165万股于2019年11月6日被解除司法轮候冻结。
2019年11月6日,公司收到《股权司法冻结及司法划转通知》,关于信达证券股份有限公司与陈德松、陈春连纠纷一案,台州市椒江区人民法院作出的执行裁定书已发生法律效力。台州市椒江区人民法院申请执行轮候冻结陈德松持有的公司无限售流通股2165万股,冻结期限为三年,自转为正式冻结之日起计算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.